SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-11-000049
Filing Date
2011-08-08
Accepted
2011-08-08 16:31:26
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmos10q063011.htm 10-Q 392384
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex311.htm EX-31.1 9437
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex312.htm EX-31.2 8534
4 SECTION 1350 CERTIFICATION ex321.htm EX-32.1 5186
5 SECTION 1350 CERTIFICATION ex322.htm EX-32.2 5064
  Complete submission text file 0001513160-11-000049.txt   1277890

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pars-20110630.xml EX-101.INS 111350
7 XBRL TAXONOMY EXTENSION SCHEMA pars-20110630.xsd EX-101.SCH 9482
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pars-20110630_cal.xml EX-101.CAL 20347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pars-20110630_lab.xml EX-101.LAB 82775
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pars-20110630_pre.xml EX-101.PRE 52250
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

IRS No.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11550 | Film No.: 111017529
SIC: 2834 Pharmaceutical Preparations